GTCbio

Arnold Gelb, Senior Biomarker Pathologist at Quest Diagnostics Clinical Trials, will give a presentation on “Applications of Biomarkers in Molecular Pathology to Therapeutic Development.” Molecular pathology is a newly established, “cross-over” discipline focused on the study of disease through examination of molecules in tissues and body fluids. This discipline includes the development, design...

Daniel Edelman, Facility Head of the Clinical Molecular Profiling Core at NCI, will give a presentation on “The Clinical Molecular Profiling Core: A New Paradigm in Personalized Cancer Care at the National Cancer Institute”. In this new age of targeted and personalized therapies, oncologists have become acutely aware that each patient and their associated tumor have their own characteristic...

PHILADELPHIA, PA – Bruce Schneider, General Medicine Team Leader, Cellular, Tissue, and Gene Therapies, at CDER/FDA will give a featured presentation at the Diabetes Summit to be held in Philadelphia, PA on March 7-8, 2011 by GTCbio. Dr. Schneider will focus on the regulation of new islet beta cell products for treatment of type 1 diabetes. This included allogeneic, embryonic stem cell, and...

John E. Sims, Scientific Executive Director at Amgen will give a featured presentation on “IL-36 Cytokines and Psoriasis” at the at 9th Cytokines & Inflammation conference to be held in San Diego, CA on January 27-28, 2011 by GTCbio. The IL-1 family is now known to comprise 11 members. Three of these – the agonists IL-1F6, IL-1F8, and IL-1F9, are expressed in only a limited set of human...

Jeremy Barton, VP of Oncology at Biogen Idec will be the keynote presenter on “Targeted Drug Delivery: How Far from the Bulls Eye?” at GTCbio’s Cancer Drugs Research & Development Conference on January 27-28, 2011 in San Diego, CA

Congressman Henry Waxman, D-CA, will give a keynote presentation discussing the legislative point of view on healthcare reform at the upcoming Healthcare Reform: Dealing with Hurdles and Building Up Successes Conference, held in Washington, DC, Nov. 8-9, 2010 by GTCbio.

Joyce Sutcliffe, Senior Vice President of Biology at Tetraphase, will give a featured presentation on “TP-434: A Novel, Gram-Negative Antibiotic in Clinical Development” at the 7th Anti-Infectives Partnering and Deal-making Summit to be held in Boston, MA on October 7-8, 2010 by GTCbio. Infections caused by multidrug-resistant (MDR) gram-negative bacterial pathogens cause great morbidity and...

Samuel McConnell, Senior Vice President of Corporate Development at Myriant Technologies will give a presentation on “Renewable Chemical Platforms and Biobased Materials” at the Future of Bio-Based Chemicals: From Inception to Marketplace conference to be held this year in San Francisco, CA on September 13-14, 2010 by GTCbio. Samuel McConnell will describe Myriant’s approach to engineering and...